PatientsVille.com Logo

PALPITATIONS and Prednisone

PatientsVille

PALPITATIONS Symptoms and Causes

An arrhythmia is a problem with the rate or rhythm of your heartbeat. It means that your heart beats too quickly, too slowly, or with an irregular pattern. When the heart beats faster than normal, it is called tachycardia. When the heart beats too slowly, it is called bradycardia. The most common type of arrhythmia is atrial fibrillation, which causes an irregular and fast heart beat.

Many factors can affect your heart's rhythm, such as having had a heart attack, smoking, congenital heart defects, and stress. Some substances or medicines may also cause arrhythmias.

Symptoms of arrhythmias include

  • Fast or slow heart beat
  • Skipping beats
  • Lightheadedness or dizziness
  • Chest pain
  • Shortness of breath
  • Sweating

Your doctor can run tests to find out if you have an arrhythmia. Treatment to restore a normal heart rhythm may include medicines, an implantable cardioverter-defibrillator (ICD) or pacemaker, or sometimes surgery.

NIH: National Heart, Lung, and Blood Institute

Check out the latest treatments for PALPITATIONS

PALPITATIONS treatment research studies

Prednisone clinical trials, surveys and public health registries


Find Drug Side Effect reports



Prednisone Side Effects

Dyspnoea (309)
Pyrexia (283)
Nausea (273)
Pain (263)
Diarrhoea (255)
Arthralgia (247)
Fatigue (246)
Headache (234)
Pneumonia (231)
Pain In Extremity (210)
Asthenia (210)
Vomiting (205)
Dizziness (201)
Oedema Peripheral (198)
Weight Increased (187)
Weight Decreased (175)
Abdominal Pain (172)
Back Pain (169)
Condition Aggravated (161)
Anaemia (156)
Crohn's Disease (113)
Sepsis (110)
Osteonecrosis (105)
Dehydration (104)
Malaise (104)
Fall (101)
Insomnia (100)
Death (100)
Injection Site Pain (100)
Chest Pain (97)
Cough (96)
Confusional State (96)
Diabetes Mellitus (91)
Rash (89)
Blood Glucose Increased (88)
Anxiety (88)
Pulmonary Embolism (88)
Rheumatoid Arthritis (85)
Pruritus (83)
Hypertension (82)
Hypotension (80)
Depression (80)
Febrile Neutropenia (79)
Erythema (78)
Renal Failure (77)
Neutropenia (74)
Deep Vein Thrombosis (73)
Renal Failure Acute (71)
Hyperglycaemia (69)
Muscular Weakness (69)

➢ More


Common Meds

Abilify (10132)
Adderall (1304)
Amlodipine (6664)
Amoxicillin (4387)
Benadryl (1568)
Celebrex (12876 )
Celexa (1342)
Cialis (2975)
Cipro (8580)
Citalopram (7792)
Crestor (18839)
Cymbalta (14373)
Doxycycline (1757)
Effexor (7289)
Flexeril (435)
Flomax (2177)
Fluoxetine (4261)
Gabapentin (4593)
Hydrocodone (2469)
Ibuprofen (8222)
Lantus (10968)
Lexapro (3499)
Lipitor (17769)
Lisinopril (8919)
Lyrica (27148)
Medrol (650)
Mirena (41254)
Mobic (957)
Morphine (5356)
Naproxen (538)
Neurontin (6501)
Oxycodone (4438)
Pradaxa (13372)
Prednisone (5926)
Prilosec (2631)
Prozac (1954)
Seroquel (27216)
Simvastatin (8348)
Synthroid (4452)
Tamiflu (5585)
Topamax (3748)
Tramadol (5054)
Trazodone (1458)
Viagra (5394)
Vicodin (1153)
Wellbutrin (6324)
Xanax (2847)
Zocor (5718)
Zoloft(6792)
Zyrtec(1669)

Recent Reviews

>:o :'(

3 weeks after i had been given 120m of predisone in a 24 hour period,i started getting dizzy spells severe enough that initially i blacked out while driving,needless to say i havent been driving my car,but i still am experiencing very bad dizzy spell

66 year old male. Good to excellent health. Non smoker, non drinker. Slowly deteriorated till all joints were swollen and eventually I became 99% immobile. Diagnosis? Spotless, Rocky Mountain Spotted Fever. (erlickiosis chaffnesis) Hospitalized, inf

Female patient 39 taking prednisone for asthma. Prednisone 20 mg 4 days on and then one day off/one day onfor8 days. Menstrual type bleeding although not during menstrual period. Severe pelvic cramps and urgency of urination. Swol

I am asthmatic (since I was very little) 36yrs old, took 40mg Prednisone for 8 days - two days later I ovulated and then I started bleeding uncontrollably. Gynae said ovaries failed as blood work tested very low and put me on Duphaston to aid drying

I have taken Prednisone for severe asthma on many occassions (including IV in hospital for 7 days) and suffered severe abdominal pain. Three years ago a gastroscopy revealed I had Duodenal ulcers and Gastritis, most likely caused from the Prednisilo

I take it when i get poison oak or ivy really bad and it takes it away in like 3 days if im fully broken out and i am highly allergic poison ivy, oak and all of that other stuff like that and this stuff helps me tremendously :-D

I take prednione 10mg : 3 tablets once daily for 3 days,then 2 tablets once daily for 3 days,then 1 tabletonce daily for 3 days, then hallf tablets for 4 days. Prednisone give more energy because I have Refractory Anemia with Ringed oblast

I was on a higher dosage - 40mg for 8 days and a few days after I stopped, I started with a 'breakthrough' bleed. Had to have blood tests taken and it showed ovarian failure which DR said could be strongly linked to Prednisone... I am not convinced i

I was recently diagnosed as having rheumatoid arthritis one of the meds prescribed was prednisone one of the side affects that i have noticed is my stomach cramps inthe evening. gonna check to see if I can get a different prescrition

I stopped taking Omeprazole 20mg after 4 days because of a side effect, strong palpitations most of the time; I stopped taking them a week ago and still have the palpitations. It's very scary........

<span style='color: #808080;'>depuis que je prends concor 5mg mes palpitations ont diminu&eacute; de beaucuop, mais un autre facheux probleme surgit: mes rapportssexuels ne durent pas plus que 5mn.

31 years old female, I usesibutramina and feel overwhelmed, palpitations, thirsty all the time, insomnia, bad humor, headaches,an state of euphoria

Anybody gets side palpitations from Dayquil?

Anyone else experience dizziness and heart palpitations?

Been given Zopiclone to take at night, only took one dosage, no sleep, had anxiety palpitations, breathlessness and now chest pain

Clobex worked great on a patch of eczema I've had for four years, in two weeks it cleared up and is still gone. However, I experienced racing heart, palpitations and dypsnea. These have not subsided despite not using Clobex for two weeks.

Developed Asthma after contacting a very bad chest infection. Was hospitalised and prescribed antibiotic and Seride 250 evohaler. Have since developed palpitations and my heart is definitely missing beats particularly when I am in bed. Also have deve

DININTEL MAKES ME SICK, MY CHEST HURTS AND THAT IS BECAUSE IT CAUSES ELEVATED BLOOD PRESSURE AND PALPITATIONS

Does tenormin tabs, cause palpitations

PALPITATIONS Clinical Trials and Studies

Treatments might be new drugs or new combinations of drugs, new surgical procedures or devices, or new ways to use existing treatments. The goal of clinical trials is to determine if a new test or treatment works and is safe. Clinical trials can also look at other aspects of care, such as improving the quality of life for people with chronic illnesses. People participate in clinical trials for a variety of reasons. Healthy volunteers say they participate to help others and to contribute to moving science forward. Participants with an illness or disease also participate to help others, but also to possibly receive the newest treatment and to have the additional care and attention from the clinical trial staff.
Rank Status Study
1 Not yet recruiting Ranolazine for Improving Symptoms of Palpitations
Condition: Ischemic Heart Disease
Interventions: Drug: Ranolazine;   Drug: Placebo
Outcome Measures: Occurrence of symptoms of Palpitations;   Occurrence of arrhythmia in case of symptoms of Palpitations
2 Unknown  Palpitations and Tachycardia in Fibromyalgia Syndrome
Condition: Fibromyalgia Syndrome
Intervention: Other: Evaluation of autonomic parameters
Outcome Measure:
3 Unknown  Use of Loop Recorders for Diagnosis of Palpitations in A&E
Condition: Palpitations
Intervention: Device: Implantable Loop Recorder
Outcome Measures: The primary endpoint of the study is the proportion of patients achieving a definite diagnosis in each of the two groups at the end of one year;   The time taken from randomisation in the A&E to making the diagnosis (if any) in each group;   The cost of achieving a diagnosis in each group
4 Recruiting Ablation of Inappropriate Sinus Tachycardia
Condition: Inappropriate Sinus Tachycardia
Intervention: Procedure: electrophysiology study and radiofrequency ablation
Outcome Measures: Improvement in:symptoms(Palpitations);quality of life;resting heart rate;mean 24 hour heart rate;heart rate variability;;   duration of symptom limited Bruce protocol exercise treadmill test;duration of exercise test required to increase rate by 20%.
5 Unknown  Influence of Nebivolol on Postmenopausal Women
Conditions: Hot Flashes;   Heart Rate;   Blood Pressure;   Endostatin;   Sexual Function
Intervention:
Outcome Measures: Number of hot flashes/Palpitations;   Hemodynamic changes;   Sexual function;   Endostatin;   Quality of life
6 Recruiting Validation of an iPhone-based Event Recorder for Arrhythmia Detection
Condition: Arrhythmia, Palpitations, Lightheadedness
Intervention: Device: Alivecor monitor and 14 day event monitor
Outcome Measure: Validation of an iPhone-based Event Recorder for Arrhythmia Detection
7 Not yet recruiting Sternal ECG Patch Comparison Trial
Conditions: Syncope;   Presyncope;   Palpitations;   Atrial Fibrillation;   Supraventricular Tachycardia
Intervention:
Outcome Measures: ECG signal quality;   Device comfort
8 Not yet recruiting Comparison of Continuous Sternal ECG Patch Monitors (Carnation and Zio) Trial
Conditions: Syncope;   Presyncope;   Palpitations;   Atrial Fibrillation;   Supraventricular Tachycardia
Intervention:
Outcome Measures: ECG signal quality;   Device comfort
9 Recruiting Acupuncture for Relieving Perimenopausal Symptoms
Condition: Perimenopause
Interventions: Other: Acupuncture;   Drug: Climen 21 Tablets
Outcome Measures: Menopause Rating Scale;   Menopausal Specific Quality of Life Questionnaire;   Average hot flash score during 24 hours;   Level of Estradiol in serum;   Level of follicle stimulating hormone in serum;   Level of luteinizing hormone in serum
10 Not yet recruiting Study to Reduce Symptoms of Premature Beats With Ranolazine
Condition: Premature Ventricular Beats
Intervention: Drug: Ranolazine
Outcome Measures: Reduction in Premature Ventricular Beats;   Changes in transthoracic echocardiographic parameters;   Frequency of Palpitations;   Reduction of Premature Atrial Beats;   Measure Temperature Rebound Rate (TRR)
11 Recruiting Using a Personal Heart Rhythm Monitor to Diagnose Paroxsymal Atrial Fibrillation in the Community
Conditions: Paroxysmal Atrial Fibrillation;   Stroke
Interventions: Device: Automated Cardiac Event Recorder;   Device: Personal Heart Rhythm Monitor
Outcome Measures: The diagnostic yield of a Personal Heart Rhythm Monitor (PHRM), used for 3 months, compared to an automated cardiac event recorder (ACER), used for 1 week, to detect all episodes of paroxysmal atrial fibrillation.;   The diagnostic yield of a Personal Heart Rhythm Monitor (PHRM), used for 3 months, compared to an automated cardiac event recorder (ACER), used for 1 week, to detect prolonged episodes of paroxysmal atrial fibrillation (defined as greater than 12 hours).;   The sensitivity and specificity of serum biomarkers to detect cases of PAF.;   The sensitivity and specificity of markers of left atrial function to predict PAF.;   The development of AF in a cohort confirmed to have frequent atrial ectopic beats (APBs) over a one year period.;   Adverse events (including stroke/TIA, myocardial infarction, significant bleeding events and death) at six and twelve month intervals.;   Stroke reduction in the local area;   Referrals to secondary care for suspected AF/Palpitations;   Participant satisfaction with the devices used in the study.
12 Recruiting Catheter Cryoablation Versus Antiarrhythmic Drug as First-Line Therapy of Paroxysmal Atrial Fibrillation
Condition: Symptomatic Paroxysmal Atrial Fibrillation Without Clinically Significant Heart Diseases
Interventions: Device: cryoballoon ablation system;   Drug: Antiarrhythmic Drugs
Outcome Measures: Freedom from any atrial arrhythmia recurrence;   quality of life;   Hospital or emergency services accesses;   Freedom from occurrence of AF;   Freedom from occurrence of documented left atrial tachycardia and left atrial flutter;   Symptomatic Palpitations burden;   Severe adverse events incidence;   Freedom from persistent AF;   Echocardiographic left atrial re-modelling;   health care utilization
13 Unknown  Registry of Unexplained Cardiac Arrest
Conditions: Cardiac Arrest;   Long QT Syndrome;   Brugada Syndrome;   Catecholamine Sensitive Polymorphic Ventricular Tachycardia;   Idiopathic Ventricular Fibrillation;   Early Repolarization Syndrome
Intervention:
Outcome Measure:
14 Recruiting Pathophysiology of Orthostatic Intolerance
Conditions: Tachycardia;   Postural Orthostatic Tachycardia Syndrome
Interventions: Radiation: DAXOR;   Procedure: QSweat;   Drug: Intrinsic Heart Rate
Outcome Measures: Physiological abnormalities in orthostatic intolerance;   blood volume;   intrinsic heart rate;   quantitative sweat testing;   residual sympathetic function after pharmacological autonomic blockade;   norepinephrine spillover
15 Recruiting Effect of a Medium Chain Triglyceride Supplemented Diet on Cognitive Function and Brain Activation in Type 1 Diabetes.
Conditions: Hypo-unawareness;   Type 1 Diabetes.
Intervention: Dietary Supplement: Medium chain triglycerides
Outcome Measures: Cognitive function tests;   Brain activity
16 Unknown  Evaluation of the Effects of L-Carnitine Injection in Patients Undergoing Hemodialysis
Conditions: Cardiac Complications;   Signs and Symptoms;   Muscle Weakness;   Anemia;   Hypotension
Intervention: Drug: L-Carnitine Injection
Outcome Measures: weakness;   improvement of hypotension and hematology profile;   reduction of erythropoietin requirement;   increase of plasma carnitine concentration;   including all the components of the primary endpoints for their further assessment;   improvement of the nutritional indexes;   intradialytic complications (muscle symptoms, dyspnea, Palpitations);   quality of life
17 Recruiting The Maintenance of Human Atrial Fibrillation
Conditions: Atrial Fibrillation;   Arrhythmias, Cardiac
Intervention:
Outcome Measure: recurrence of atrial fibrillation
18 Unknown  Amiodarone Compared to Dronedarone , Post Cardioversion Maintenance of Sinus Rhythm
Condition: Atrial Fibrillation
Interventions: Drug: amiodarone;   Drug: Dronedarone
Outcome Measures: maintenance of sinus rhythm at one year post DC Cardioversion;   tolerability of amiodarone compared to dronedarone;   measures of quality of life and symptoms in amiodarone compared to dronedarone
19 Not yet recruiting Early Elimination of Premature Ventricular Contractions in Heart Failure
Conditions: Premature Ventricular Contractions;   Congestive Heart Failure
Intervention: Device: PVC ablation
Outcome Measures: change of left ventricular ejection fraction measured with Simpson's rule expressed in percent from pre to post intervention;   Change of echocardiographic Parameters;   Change in serum biomarker level;   Change in Heart Failure Symptoms
20 Recruiting The Leiden Nonischemic Cardiomyopathy Study
Conditions: Cardiomyopathy, Dilated;   Tachycardia, Ventricular;   Ventricular Fibrillation
Interventions: Other: Transthoracic echocardiography;   Other: Exercise test;   Other: 24-hour Holter electrocardiogram;   Other: Contrast-enhanced magnetic resonance imaging;   Other: 123-iodine metaiodobenzylguanidine imaging;   Other: Blood samples;   Genetic: Genetic analysis;   Procedure: Invasive electrophysiological study;   Procedure: Endomyocardial biopsy;   Procedure: Intraoperative biopsy;   Procedure: Intraoperative mapping and/or ablation
Outcome Measures: Inducibility of ventricular arrhythmias;   Type of induced ventricular arrhythmias;   Spontaneous ventricular arrhythmias;   Type of spontaneous ventricular arrhythmias;   Hospital admissions for heart failure;   Cardiac mortality;   All-cause mortality;   LV function/dimensions/compact fibrosis deterioration as assessed by 123-I MIBG imaging and/or CE-MRI